Bottom line
What is MAFAX's expense ratio?
MAFAX's expense ratio is 2.05%, or about $205 a year on every $10,000 invested. That is more expensive than 94% of large blend funds we track (median 0.83%). This share class also charges a front-end sales load of up to 5.75%, taken from your investment when you buy. Its expense ratio includes a 0.25% 12b-1 marketing fee.
Updated Jan 5, 2026
MAFAX fee table
| Net expense ratio | 2.05% |
|---|---|
| Gross expense ratio | 2.13% |
| Management fee | 1.77% |
| 12b-1 (distribution) fee | 0.25% |
| Other expenses | 0.1% |
| Acquired fund fees | 0.01% |
| Fee waiver / reimbursement | -0.08% |
| Max front-end sales load | 5.75% |
| Max deferred sales charge | 0% |
| Redemption fee | 0% |
Source: Fund prospectus fee table, filed Jan 5, 2026
What MAFAX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| MAFAX | $771 | $1,196 | $1,646 | $2,890 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 2.05% expense ratio costs roughly $103,700 in lost growth, versus about $46,700 for the median large blend fund (0.83%).